CA2083583A1 - Epreuve diagnostique pour la sclerose en plaques - Google Patents

Epreuve diagnostique pour la sclerose en plaques

Info

Publication number
CA2083583A1
CA2083583A1 CA 2083583 CA2083583A CA2083583A1 CA 2083583 A1 CA2083583 A1 CA 2083583A1 CA 2083583 CA2083583 CA 2083583 CA 2083583 A CA2083583 A CA 2083583A CA 2083583 A1 CA2083583 A1 CA 2083583A1
Authority
CA
Canada
Prior art keywords
patient
plasma
protein
multiple sclerosis
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2083583
Other languages
English (en)
Inventor
Roy L. Swank
Roy A. Garvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2083583A1 publication Critical patent/CA2083583A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CA 2083583 1990-03-30 1991-04-01 Epreuve diagnostique pour la sclerose en plaques Abandoned CA2083583A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50225890A 1990-03-30 1990-03-30
US502,258 1990-03-30

Publications (1)

Publication Number Publication Date
CA2083583A1 true CA2083583A1 (fr) 1991-10-01

Family

ID=23997019

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2083583 Abandoned CA2083583A1 (fr) 1990-03-30 1991-04-01 Epreuve diagnostique pour la sclerose en plaques

Country Status (3)

Country Link
EP (1) EP0525091A1 (fr)
CA (1) CA2083583A1 (fr)
WO (1) WO1991015765A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8501682A (nl) * 1985-06-11 1987-01-02 Tno Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten.
US4810657A (en) * 1987-10-19 1989-03-07 Swank Roy L Method of diagnosing multiple sclerosis and other diseases by measurement of blood plasma protein streaming potential

Also Published As

Publication number Publication date
WO1991015765A1 (fr) 1991-10-17
EP0525091A1 (fr) 1993-02-03
EP0525091A4 (fr) 1994-03-23

Similar Documents

Publication Publication Date Title
Stibler et al. Clinical significance of abnormal heterogeneity of transferrin in relation to alcohol consumption
Stone et al. Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction.
Kuriyama et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay
Kueppers Genetically determined differences in the response of alpha1-antitrypsin levels in human serum to typhoid vaccine
Legaz et al. Electrophoretic amylase fractionation as an aid in diagnosis of pancreatic disease.
JP5330381B2 (ja) 酸化還元電位（ｏｒｐ）を測定及び使用する方法
US8846413B2 (en) Method for determining the concentration of the adipocytic form of the fatty acid binding protein (A-FABP, FABP4, P2)
Jones et al. Membrane abnormalities in Duchenne muscular dystrophy
US4436824A (en) Leukocyte migration through antigen containing agaroses for immunocompetence testing
Nemes et al. Nε (γ-glutamyl) lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia
Green et al. Normal serum alkaline phosphatase isoenzymes examined by acrylamide and starch gel electrophoresis and by isoenzyme analysis using organ-specific inhibitors
Rudman et al. Novel proteins and peptides in the urine of patients with advanced neoplastic disease
KR100689995B1 (ko) 알돌라제를 포함하는 망막혈관 질환 진단용 조성물 및 그진단방법
US5284749A (en) Diamine oxidase and assay for rupture of amniotic membrane in pregnant mammals
US20050124011A1 (en) Diagnosis of disease using tears
Saito et al. Marked increases in concentrations of apolipoprotein in the cerebrospinal fluid of poliovirus-infected macaques: relations between apolipoprotein concentrations and severity of brain injury
Bonting et al. Quantitative histochemistry of the nephron. VI. Hydroxyproline in the human glomerulus
CA2083583A1 (fr) Epreuve diagnostique pour la sclerose en plaques
Thomas et al. Electrophoretic analysis of serum proteins in cystic fibrosis
Weaver et al. Aged amylase: a valuable test for detecting and tracking pancreatic pseudocysts
JPH1090263A (ja) アルツハイマー病の診断のためのｅｒｋ−１およびｅｒｋ−２の利用
Nussinovitch et al. Increased creatine kinase brain isoenzyme concentration in cerebrospinal fluid with meningitis
Hunter et al. Fibrin/fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit
Kobayashi et al. Absence of argininosuccinate lyase protein in the liver of two patients with argininosuccinic aciduria
Grataroli et al. Detection of the cystic fibrosis protein by isoelectric focusing of serum and plasma

Legal Events

Date Code Title Description
FZDE Dead